The American College of Cardiology has issued a Concise Clinical Guidance (CCG) document to aid clinicians in the use of ...

A new study has found that people with type 2 diabetes who take semaglutide—a drug commonly known by its brand names Ozempic ...

Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

The American College of Cardiology has issued new guidelines recommending weight management medications as first-line ...

With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, with many patients quitting GLP-1 treatment within a year.

GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...

May also include heart failure, rehospitalization for cardiovascular causes, and other cardiovascular endpoints. MALE Variably defined but usually includes major amputation and endovascular or ...

As more people resort to a new generation of drugs to achieve the perfect body, Leah Hardy examines the latest warnings over ...

The doctor tells how Ozempic might be a new boon for treating heart health problems like strokes heart attack etc ...

New research shows GLP-1 drugs may be linked to a twofold increase in the risk of wet AMD among people with diabetes.